Inpharmatica in ADME services deal with British Biotech

FRAMINGHAM (10/21/2003) - Drug discovery company Inpharmatica Ltd. has entered into a two-year agreement with biopharmaceutical company British Biotech, which will use Inpharmatica absorption, distribution, metabolism, and excretion (ADME) services in its drug discovery process. As part of the deal, an Inpharmatica ADME consultant will join British Biotech research projects and manage the joint ADME work carried out by an Inpharmatica team. This team will provide assays, analysis, and interpretation of ADME data for a number of British Biotech drugs that are in its pipeline. The financial terms of the deal were not revealed.

Join the newsletter!


Sign up to gain exclusive access to email subscriptions, event invitations, competitions, giveaways, and much more.

Membership is free, and your security and privacy remain protected. View our privacy policy before signing up.

Error: Please check your email address.

More about British Biotech

Show Comments